Yahoo
    Swiss - Delayed Quote CHF

    PolyPeptide Group AG (PPGN.SW)

    Get top stock picks
    43.95 -0.05 (-0.11%)
    As of 1:34:16 PM GMT+2. Market Open.
    Get top stock picks
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for PPGN.SW
    • Previous Close 44.00
    • Open 44.00
    • Bid 43.95 x --
    • Ask 44.00 x --
    • Day's Range 43.95 - 44.05
    • 52 Week Range 21.80 - 50.10
    • Volume 22,665
    • Avg. Volume 132,319
    • Market Cap (intraday) 1.451B
    • Beta (5Y Monthly) 1.00
    • PE Ratio (TTM) 107.20
    • EPS (TTM) 0.41
    • Earnings Date Aug 13, 2026
    • Forward Dividend & Yield --
    • Ex-Dividend Date Apr 28, 2022
    • 1y Target Est 39.50

    PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

    www.polypeptide.com

    1,460

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about PolyPeptide Group AG

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 8/31/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

    YTD Return

    PPGN.SW
    68.39%
    MSCI WORLD (^990100-USD-STRD)
    11.80%

    1-Year Return

    PPGN.SW
    62.18%
    MSCI WORLD (^990100-USD-STRD)
    19.30%

    3-Year Return

    PPGN.SW
    76.51%
    MSCI WORLD (^990100-USD-STRD)
    66.61%

    5-Year Return

    PPGN.SW
    67.90%
    MSCI WORLD (^990100-USD-STRD)
    58.40%

    Analyst Insights

    View More

    Analyst Price Targets

    25.96 Low
    39.50 Average
    43.95 Current
    44.21

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual
    As of 8/27/2026

    • Market Cap

      1.45B

    • Enterprise Value

      1.53B

    • Trailing P/E

      106.70

    • Forward P/E

      68.97

    • PEG Ratio (5yr expected)

      --

    • Price/Sales (ttm)

      3.25

    • Price/Book (mrq)

      4.41

    • Enterprise Value/Revenue

      3.45

    • Enterprise Value/EBITDA

      21.42

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      3.15%

    • Return on Assets (ttm)

      3.38%

    • Return on Equity (ttm)

      4.24%

    • Revenue (ttm)

      458.86M

    • Net Income Avi to Common (ttm)

      14.45M

    • Diluted EPS (ttm)

      0.41

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      59.03M

    • Total Debt/Equity (mrq)

      42.48%

    • Levered Free Cash Flow (ttm)

      -92.61M

    View More

    Compare

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    PPGN.SW
    PolyPeptide Group AG
    43.95
    -0.11%
    Mkt Cap CHF 1.451B
    Industry Drug Manufacturers—Specialty & Generic
    W041.F
    Digital Commodities Inc.
    0.0070
    -6.67%
    Mkt Cap EUR 1.181M
    Industry Capital Markets
    SFZN.SW
    Siegfried Holding AG
    73.00
    -1.55%
    Mkt Cap CHF 3.198B
    Industry Drug Manufacturers—Specialty & Generic
    SDZ.SW
    Sandoz Group AG
    68.10
    -1.16%
    Mkt Cap CHF 29.466B
    Industry Drug Manufacturers—Specialty & Generic
    CRON
    Cronos Group Inc.
    3.3800
    -0.29%
    Mkt Cap 1.245B
    Industry Drug Manufacturers—Specialty & Generic
    VTRS
    Viatris Inc.
    16.34
    -3.26%
    Mkt Cap 18.768B
    Industry Drug Manufacturers—Specialty & Generic
    RGC
    Regencell Bioscience Holdings Limited
    5.50
    -0.36%
    Mkt Cap 2.72B
    Industry Drug Manufacturers—Specialty & Generic
    AQST
    Aquestive Therapeutics, Inc.
    5.02
    -2.71%
    Mkt Cap 630.068M
    Industry Drug Manufacturers—Specialty & Generic
    TLRY
    Tilray Brands, Inc.
    4.5900
    +0.44%
    Mkt Cap 631.496M
    Industry Drug Manufacturers—Specialty & Generic
    HIMS
    Hims & Hers Health, Inc.
    28.84
    -8.91%
    Mkt Cap 6.729B
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    BANB.SW Bachem Holding AG
    75.60 -1.75%
    SFZN.SW Siegfried Holding AG
    73.00 -1.55%
    COTN.SW Comet Holding AG
    335.00 -2.05%
    TECN.SW Tecan Group AG
    194.90 +0.26%
    YPSN.SW Ypsomed Holding AG
    395.00 -1.35%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: